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chromatographyAbstract Reduction of matrix effect seems to be a great challenge for the development of a prac-
tical method in bioanalysis. In this regard, a simple and efﬁcient DLLME procedure along with a
back-extraction step (DLLME-BE) was developed for the preconcentration of four common non-
steroidal anti-inﬂammatory drugs (NSAIDs) in various biological ﬂuid samples. Brieﬂy, the ana-
lytes of interest were initially transferred into the extraction solvent followed by the back-
extraction into an immiscible basic methanol (as an acceptor phase) for further preconcentration
and clean-up. The main purpose of the work is reducing the matrix effect and sensitive determina-
tion of target molecules in the complex matrices. Following on, the separation and determination of
the analytes were carried out using GC–MS (in-port derivatization) and HPLC-DAD instrument.
The inﬂuential parameters affecting the DLLME-BE method were evaluated in detail and the best
extraction conditions were established. Under the optimum conditions, low method detection limits
in the range of 0.1–1.0 and 0.1–6.0 mg L1 were obtained for GC–MS and HPLC-DAD analysis,ed with
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back extraction for trace determination of arespectively. Additionally, fair intra-day precisions of 2.7–14.5 and 2.8–7.8% as well as inter-day
precisions of 3.9–14.5 and 3.5–8.1% were achieved for the GC–MS and HPLC-DAD analysis,
respectively. Finally, the method was successfully applied for the determination of four common
NSAIDs in different biological ﬂuid samples.
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Non-steroidal anti-inﬂammatory drugs (NSAIDs) are classi-
ﬁed as pharmaceuticals and personal care products (PPCPs)
(Zhang et al., 2013) commonly prescribed for the treatment
of a wide variety of pain-related diseases. This class is made
up of salycilic acid, ibuprofen, ketoprofen, naproxen,
ﬂuribuprofen, diclofenac, phenoprofen and ketorolac.
Although NSAIDs are regarded as low-risk, they may cause
intensive toxic effects in cases of acute over-dosage or chronic
abuse (Kim and Aga, 2007). Thus, their detection in biological
ﬂuid samples is of great importance.
Despite a huge progress recently made in the sample
pretreatment procedures, sample pretreatment is still
regarded as the crucial step in the modern analytical tech-
niques. Generally, turning an analyte into a pre-puriﬁed,
concentrated, which is compatible with the analytical instru-
ment, is vital in the sample preparation. Many attempts
have been made for the development of such efﬁcient,
low-cost, and miniaturized sample preparation methods.
So far, various modes of solid- and liquid-phase microex-
traction (LPME) (Bazregar et al., 2016; Barﬁ et al., 2015;
ParrillaVa´zquez et al., 2013; Toledo-Neira and A´lvarez-
Lueje, 2015) have been developed. LPME is an emerging
technique, which is based on the low consumption of
organic solvents, mainly used for the extraction of analytes
from aqueous matrices.
Further on, Rezaee et al. reported a LPME method known
as DLLME (Rezaee et al., 2006), which has gained tremendous
attentions for its simplicity and ability to provide high extrac-
tion efﬁciencies within a short period of time. Nevertheless,
DLLME as a one-step extraction technique, suffers from inad-
equate clean-up and low reproducibility in trace analysis asso-
ciated with highly complicated matrices (Guo and Lee, 2013;
Sima˜o et al., 2016). To reduce the mentioned problems, the
coupling of DLLME with back-extraction step based on the
implementation of two immiscible organic solvents, as an
improved kind of DLLME, was ﬁrst introduced by
Ghambarian et al. (2016).
To analysis of non-steroidal anti-inﬂammatory drugs a
sample preparation step is necessary for reducing of matrix
effect before analysis by instrumental analysis (Mzukisi
Madikizela et al., 2018; Kamaruzaman et al., 2013; Sultan
et al., 2005; Bazregar et al., 2016; Gouda et al., 2013).
In the present work, a DLLME-BE method prior to
HPLC-DAD/GC–MS analysis was applied for the preconcen-
tration of the selected NSAIDs (ibuprofen, naproxen, ketopro-
fen, and diclofenac). In fact, the back-extraction step improves
sensitivity, reproducibility and clean-up to a great extent. The
novelty of the work was back extraction step that provided
two main advantages in comparison to previously DLLME
methods as follows:n, M. et al., An eﬃcient sample prepar
cidic pharmaceuticals. Arabian Journal1- In fact, we did extract the biological samples using the
DLLME stage alone and what we achieved was the
organic extract phase (2-dedcane and TOPO) full of
unwanted materials which overwhelmed the whole phase
resulting in an enhancement of background signals and
interferences within the matrix.
2- Additionally, the introduction of the above-mentioned
extract phase (2-dedcane and TOPO) to GC and HPLC
could hamper the whole analysis and does severe dam-
ages to the used chromatographic instruments.
In GC–MS case, since the studied NSAIDs (ibuprofen,
naproxen, ketoprofen, and diclofenac) are classiﬁed as polar
carboxylic acids, they should be identiﬁed and quantiﬁed in
their corresponding silyl ester forms (Rodriguez et al., 2003;
Yu et al., 2007; Rice and Mitra, 2007). The silyl derivatives
were prepared using N-Methyl-N-(trimethylsilyl) triﬂuoroac-
etamide (MSTFA) acting as a silylating reagent. It is worth
noting that the analytes were instantly derivatized inside the
hot GC–MS injector port (in-port derivatization), which elim-
inates the lengthy reaction time needed in conventional in-vial
silylation.
Considering the above-mentioned points, for these polar
analytes the back-extraction step not only improved the repro-
ducibility and clean-up but also minimized the matrix effect
prior to both chromatographic analyses.
2. Materials and methods
2.1. Materials and samples
Naproxen (NAP), Ketoprofen (KET), ibuprofen (IBU), and
diclofenac (DIC) (all with the purity of 98%) used in this
study were supplied by Sigma–Aldrich (Steinheim, Germany).
MSTFA (99.8% purity), potassium hydroxide, trioctylphos-
phine oxide (TOPO) and Triﬂuoroacetic acid (TFA) were also
purchased from Sigma–Aldrich (Steinheim, Germany). Ultra-
pure water and HPLC-grade methanol were purchased from
Samchun (Pyeongtaek, South Korea). Urine and plasma
samples containing the drugs were delivered by two patients.
All samples were collected in accordance with the ethical
guidelines and permission of institutional review board
(IRB), and the urine and plasma samples were stored at
4 C and 20 C, respectively. The drug-free plasma and urine
samples were provided from the Hakim Medical Clinic
(Tehran, Iran) and used for the plotting the calibration curves
(matrix-matched calibration). The pH of the sample solutions
were adjusted at 1.0 by a drop-wise addition of 1 mol L1
HNO3 solution. A stock solution (1000 mg L
1 in MeOH)
of each drug was prepared and stored at 4 C. The stock
solutions were then mixed and used for the fortiﬁcation of
water, urine and plasma samples. Method optimization wasation method based on dispersive liquid–liquid microextraction associated with
of Chemistry (2018), https://doi.org/10.1016/j.arabjc.2018.02.010
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100 mg L1 with respect to each drug.
2.2. Instrumental
An Agilent HPLC instrument (Wilmington, USA) equipped
with an Agilent G1315D diode array detector (DAD), a 1200
series quaternary pump and an Agilent Eclipse-XDB-C18 ana-
lytical column (150 mm  4.6 mm, 5 mm) was applied to sepa-
rate and detect the analytes. The aqueous mobile phase was
initially composed of 40% methanol (component A) and
60% formic/format buffer at pH 2 (component B). While run-
ning the solvent gradient program, from 0 to 5 min the concen-
tration of component A linearly increased to 80%, then
ramped to 100% at 10 min (the total run takes 10 min). The
mobile phase ﬂow rate and injection volume were set at 1
mL min1, and 15 mL, respectively. DAD monitoring wave-
lengths were adjusted at 210 nm for KET, IBU, and DIC
and 220 nm for NAP, respectively.
GC–MS analyses were made on an Agilent 7890 gas chro-
matograph (Centerville Road, Wilmington, NC, USA)
equipped with a multi-mode inlet (MMI) of an electrospray
ionization mode (ESI, 1200 eV) and a mass range of 50–700
amu. The separation was performed on a HP-5 fused silica
capillary column (30 m  0.32 mm id, 0.25 mm ﬁlm thickness)
provided by the Supelco (Bellefonte, PA, USA). Helium (pur-
ity 99.999%) was employed as the carrier gas at a ﬂow rate of
1.0 mL min1. Samples were injected in programmed tempera-
ture vaporization (PTV) mode, so that within 5 min the injec-
tor temperature was raised to 280 C. The GC oven was
initially held at 70 C for 2 min, then ramped to 280 C at
25 C min1, and ﬁnally held for 15 min. The solvent cut-off
time was set at 5 min. The retention times for the studied com-
pounds were as follows:
IBU (8.5 min), NAP (10.5 min), KET (11.9 min), and DIC
(13.1 min).
Four ions with respect to each NSAID (as trimethylsylil
(TMS) derivative) were selected under SIM acquisition mode
(dwell time of 100 ms) for identiﬁcation and quantiﬁcation as
follows: IBU-TMS, m/z 161, 234, 263, 278; KET-TMS, m/z
105, 282, 311, 326; DIC-TMS, m/z 214, 242, 277, 367; NAP-
TMS, m/z 185, 243, 287, 302.
2.3. Sample procedure
For breaking down the drug–protein bindings and liberation
of the drugs from the plasma matrix, a protein-precipitationFig. 1 A scheme for presentation of the i
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added to 1.0 mL of plasma and the resulting mixture was vig-
orously vortexed for 2 min. The mixture was placed on ice for
5 min, kept for 2 min at room temperature, and then cen-
trifuged at 4000 rpm for 5 min. The supernatant solution was
transferred into a 5-mL sample vial and made up to the mark
with ultrapure water while being pH-adjusted at 1.0. Finally,
the mixture underwent the extraction procedure under the
optimal conditions. Meanwhile, in order to reduce the matrix
effects in the urine sample, the sample was diluted 2:5 with
ultrapure water and the pH of the sample was adjusted to
1.0 as well.
In the extraction step, a 5-mL sample solution was poured
into a sample vial. The mix of acetone (disperser solvent, 1.00
mL) and n-dodecane/TOPO (95:5, v/v) (extraction solvent,
200 mL), was quickly transferred into the solution using a
2.00 mL syringe. A turbid solution (water/acetone/n-
dodecane with 5% TOPO) instantly appeared in the vial. Fol-
lowing that, the NSAIDs were extracted from the sample into
the super tiny drops of the extraction solvent through a 5-min
vortex agitation. The resulting mixture was then centrifuged
for 5 min at 4000 rpm. After that, the dispersed tiny drops of
the extraction solvent were collected on the top of the aqueous
phase (160 ± 5 mL) and transferred into a 2 mL centrifuge
tube. In the next step, 20 lL basic MeOH was swiftly added
into the above tube and vortexed for 30 s. In this step, the ana-
lytes were extracted to the acceptor phase (basic MeOH). After
the centrifugation, the lower acceptor phase was withdrawn, of
which, 15 mL was injected into the HPLC-DAD. The rest of
acceptor phase (5 mL) was vaporized to dryness and combined
with 5 mL of MSTFA, of which, 2 mL was injected into the
GC–MS. As mentioned earlier, the derivatization step was car-
ried out in the injection port of GC–MS (in-port derivatiza-
tion) (Danielson et al., 2000). The scheme for the proposed
sample preparation method was presented in Fig. 1.
3. Results and discussion
3.1. Optimization of DLLME-related parameters
(a) Kind and volume of the extraction solvent
Initial experiments were carried out using 1.00 mL of ace-
tone and 200 mL of an extraction solvent whilst no salt was
used. For this purpose, a number of extraction solvents such
as dichloromethane, 1-octanol, 1-undecanol, n-dodecane, n-
dodecane/TOPO (95:5, v/v), and 1-octanol/TOPO (95:5, v/v)
were evaluated to ﬁnd the best extraction solvent. Also, itntroduced sample preparation method.
ation method based on dispersive liquid–liquid microextraction associated with
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by the inclusion of TOPO, which led to the enhancement of the
extraction efﬁciency. As can be clearly deducted from Fig. 1S
(Electronic supplementary materials (ESM)), amongst the sol-
vents used, n-dodecane/TOPO (95:5, v/v) provided the highest
extraction efﬁciencies. Thus, it was selected as the optimal
extraction solvent for further experiments. Additionally, the
impact of the content of TOPO in n-dodecane was evaluated
in the span of 1–15% v/v. The results indicated that the trans-
port of analytes increased with the rise of TOPO content from
1 to 5%. Further increases in the carrier content from 5 to
15% had almost negligible inﬂuence on the extraction efﬁcien-
cies (data not shown).
In order to assess the inﬂuence of the extraction solvent vol-
ume, different volumes of the selected extraction solvent (75,
100, 150, 200, and 250 mL) and a ﬁxed volume of acetone
(1.00 mL) were employed Fig. 2A). It was found out that by
increasing the volume from 75 to 200 mL, the extraction efﬁ-
ciencies were enhanced. Thus, 200 mL of n-dodecane/TOPO
(95:5, v/v) was selected as the optimal solvent extraction vol-
ume. It is also noted that the volume of the extraction solvent
collected was determined to be 160 ± 5 mL (n = 15).
(b) Kind and volume of disperser solvent
For assessing the impact of disperser solvent on the extrac-
tion efﬁciency of the method and obtaining the optimal dis-
perser solvent, different organic solvents including ACN,
MeOH, and acetone were investigated, each at 1.00 mL level.
Amongst these, acetone exhibited better miscibility withFig. 2 Effect of volume of extraction solvent (A), pH of sample so
solvent: 1 mL acetone; acceptor solvent: MeOH).
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highest extraction efﬁciencies. It should be noted that ACN
and MeOH are immiscible with n-dodecane as well. Hence,
acetone was selected as the disperser solvent in the following
experiments. Further on, various volumes of acetone (0.25,
0.50, 1.00, 1.50, and 2.00 mL) in conjunction with the extrac-
tion solvent (200 mL) were tested. The results clearly indicated
that extraction efﬁciencies were increased up to 1.00 mL and
decreased thereafter, which could be attributed to the fact that
the implication of high content of acetone leads to a higher sol-
ubility of NSAIDs in the aqueous phase. Consequently, 1.00
mL of acetone was selected as the optimum disperser solvent
volume.
(c) Effect of pH
As a rule of thumb, pH is a major contributor involved in
the extraction efﬁciency especially for acidic/basic analytes.
With regard to pKa of the analytes, the transport of the ana-
lytes from the sample solution to the extraction solvent is
highly affected by the variation of pH in the sample solution.
As the studied analytes are acidic, the alteration of pH should
change their respective forms (i.e., neutral molecular and/or
ion form). As expected, under low pH values the neutral forms
of the analytes are predominantly present in the sample solu-
tion, so that they are easily extracted to the extraction solvent.
As clearly shown in Fig. 2B, the extraction efﬁciencies dropped
down with an increase in the pH of the donor phase from 1 to
3. Therefore, pH 1 was chosen for the subsequent experiments.lution (B), salt addition (C) and extraction time (D). (Disperser
ation method based on dispersive liquid–liquid microextraction associated with
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It was revealed that the extraction efﬁciencies fell down
with increasing the salt concentration from 0 to 10.0% (w/v),
as depicted in Fig. 2C. It was also observed that the appear-
ance of the turbid solution was hampered when higher
amounts of salt (10%) were added to the sample solution.
This could be explained by the fact that the miscibility of ace-
tone with water is reduced as a result. Hence, no salt was
added in the subsequent experiments.
In a further study, the inﬂuence of extraction time was also
examined in the span of 0.5–10 min whilst the other experimen-
tal conditions were set at their respective ﬁxed levels. The
results clearly exhibits that the extraction efﬁciency increased
with extending the extraction time from 0.5 to 5 min. Beyond
5 min, the impact of extraction time on the extraction efﬁciency
was found to be negligible Fig. 2D). Thus, 5 min was used as
the best extraction time in further experiments.
3.2. Optimisation of back-extraction conditions
In order to ﬁnd the best back-extraction solvent, a number of
organic solvents such as MeOH, ACN, dihexylether (DHE),
tetrahydrofuraan (THF) and water, which all are immiscible
with n-dodecane/TOPO (95:5, v/v), were tested. They were
all basiﬁed to facilitate the back-extraction of the analytes. It
was observed that the mass transfer of the analytes from the
extraction solvent to the basiﬁed back-extraction solvent wasTable 1 Figures of merit of the proposed sample preparation meth
Method Matrix NSAIDs Calibration
parameters
Figure of m
LDRa
(mg L1)
R2 PF MD
(mg L
DLLME-BME/
HPLC-DAD
Plasma KET 4.0–400.0 0.992 37 1.0
NAP 4.0–400.0 0.981 23 1.0
DIC 25–400.0 0.988 19 6.0
IBU 25–400.0 0.981 22 6.0
Urine KET 2.0–400.0 0.998 78 0.5
NAP 2.0–400.0 0.972 47 0.5
DIC 15–400.0 0.992 36 5.0
IBU 15–400.0 0.986 47 5.0
Water KET 0.5–400.0 0.999 215 0.1
NAP 1.0–400.0 0.996 145 0.3
DIC 5.0–400.0 0.999 97 1.0
IBU 5.0–400.0 0.982 129 1.0
DLLME-BME/
GC–MS
Plasma KET 2.5–400.0 0.982 38 0.5
NAP 2.0–400.0 0.999 24 0.5
DIC 5.0–400.0 0.999 21 1.0
IBU 5.0–400.0 0.998 23 1.0
Urine KET 1.0–400.0 0.999 75 0.3
NAP 1.0–400.0 0.989 49 0.3
DIC 2.0–400.0 0.999 37 0.5
IBU 2.0–400.0 0.989 48 0.5
Water KET 0.5–400.0 0.997 219 0.1
NAP 0.5–400.0 0.998 149 0.1
DIC 0.5–200.0 0.999 101 0.2
IBU 0.5–200.0 0.968 135 0.2
a Linear dynamic range.
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The results also demonstrated that the highest attainable
extraction efﬁciencies were obtained when basic methanol
was implemented as the acceptor phase (Supporting Informa-
tion Fig. 2S (ESM)). We should say that the back-extraction
stage in this work is performed to address two major issues
as following:
1- In fact, we did extract the biological samples using the
DLLME stage alone and what we achieved was the
organic extract phase (2-dedcane and TOPO) full of
unwanted materials which overwhelmed the whole phase
resulting in an enhancement of background signals and
interferences within the matrix.
2- Additionally, the introduction of the above-mentioned
extract phase (2-dedcane and TOPO) to GC and HPLC
could hamper the whole analysis and does severe dam-
ages to the used chromatographic instruments.4. Method validation
The validation of the method was carried out under the opti-
mal conditions by investigating the following parameters: lin-
ear range, preconcentration factor (PF), MDL and LOQ,
precision (RSD %), accuracy (Error %) and matrix effect.
The LOQs were calculated according to the following
criterium:od.
erits
L
1)
LOQ
(mg L1)
ER
%
% RSD (n = 3)
Intra-assay Inter-assay
20
(mg L1)
100
(mg L1)
20
(mg L1)
100
(mg L1)
4.0 74.0 4.8 4.2 5.2 4.8
4.0 46.0 3.5 3.1 4.1 3.6
25.0 38.0 5.9 5.7 6.2 5.8
25.0 44.0 5.3 3.9 5.7 4.5
2.0 78.0 5.7 5.2 6.3 6.2
2.0 47.0 6.1 5.5 6.7 6.2
15.0 36.0 5.2 4.7 5.9 5.0
15.0 47.0 7.8 7.0 8.1 7.5
0.5 86.0 3.5 3.1 4.2 3.5
1.0 58.0 3.2 3.9 5.0 3.7
5.0 38.8 4.6 2.8 5.1 4.4
5.0 51.6 4.9 4.5 5.2 4.9
2.5 76.0 11.7 10.2 12.1 11.3
2.0 48.0 13.5 12.3 13.0 12.5
5.0 42.0 10.6 9.9 11.1 10.8
5.0 46.0 12.5 11.0 13.0 11.7
1.0 75.0 14.0 9.8 14.2 10.1
1.0 49.0 3.5 2.7 4.7 3.9
2.0 37.0 11.6 10.5 11.7 11.3
2.0 48.0 12.9 11.4 12.5 12.0
0.5 82.0 14.5 14.1 14.2 13.8
0.5 56.0 12.3 11.1 12.6 11.5
0.5 39.6 14.2 13.4 14.5 14.1
0.5 54.0 13.8 12.5 13.5 13.2
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Fig. 3 HPLC-DAD chromatograms of a real urine 1 (A) and
plasma 2 (B) samples before (2) and after (1) spiking with NSAIDs
standard solution at concentration level of 200 mg L1.
6 M. Ghambarian et al.The lowest detectable concentration level at which the accu-
racy and precision fall within the ranges of 80–120 and 0–20%,
respectively.
Matrix effect was also evaluated in drug-free water, urine,
and plasma samples, according to the FDA recommendations
(Food and Drug Administration, 2013). As presented in
Table 1, the calibration curves were linear over the range of
0.5–400.0 mg L1 for DLLME-BE followed by HPLC-DAD
and GC–MS. The MDLs were calculated on the basis of
signal-to-noise ratios of 3, which were in the ranges of 0.1–
1.0 for GC–MS and 0.1–6.0 mg L1 for HPLC-DAD. The
LOQs obtained were in the range of 0.5–5.0 and 0.5–25 mg
L1 for GC–MS and HPLC-DAD, respectively. Inter- and
intra-assay (as the index of precision/repeatability) were calcu-
lated with three determinations at two concentration levels (20
and 100 mg L1 for each drug (QCs)). The PFs were deter-
mined to be in the range of 19–219. According to the FDA
guidelines, matrix effect is the direct or indirect alteration or
interference in a response due to the presence of unintended
analytes or other interfering substances in the sample. No sig-
niﬁcant interfering peaks were observed at the retention times
of the target analytes following the extraction from the water
and real samples. In this study, the matrix effect was deter-
mined by comparing the absolute peak areas in the neat solu-
tions with those obtained at each level of the standard fortiﬁed
(50 and 200 mg L1 (QCs)) for the six real samples
(Matuszewski et al., 2003). Additionally, all validation steps
for the DLLME-BE/GC–MS procedure were carried out and
the results are presented in Table 2.
4.1. Analysis of real samples
The applicability of the proposed method for the measurement
of the studied analytes in two real biological ﬂuid samples
(urine and plasma) was assessed. The samples were collectedTable 2 Analytical results for the extraction and determination of
Sample Analyte Found ± SDb (n = 3)
Cadded
a = 0 mg L1
Found
Cadded =
Urine 1 KET <LODc 195.3 ±
NAP <LOD 204.3 ±
DIC <LOD 210.4 ±
IBU 246.5 ± 11.5 451.2 ±
Plasma 1 KET <LOD 185.4 ±
NAP <LOD 191.3 ±
DIC <LOD 204.7 ±
IBU 170.7 ± 5.7 365.4 ±
Urine 2 KET <LOD 198.4 ±
NAP 56.4 ± 20.7 230.0 ±
DIC <LOD 201.4 ±
IBU <LOD 188.2 ±
Plasma 2 KET <LOD 201.4 ±
NAP 42.9 ± 2.5 225.8 ±
DIC <LOD 194.4 ±
IBU <LOD 205.7 ±
a Added concentration.
b Standard deviation.
c Not detected.
d Relative recovery.
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then placed in the fridge until the time of analysis.
Then, the target analytes were extracted under the optimal
conditions. The Error, and RSD% for the analysis of NAP,
KET, DIC and IBU in plasma and urine samples were deter-
mined based on three measurements Table 2. Relative recover-
ies (RR%) were calculated using the following expression:
RR% ¼ 100 ðCfoundCrealÞ=Cadded
where Cfound and Cadded are the concentrations of the analytes
in the samples after and before the addition of a known quan-
tity of the standard solutions. Fig. 3 represents the HPLC-
DAD chromatograms of the real urine (A) and plasma (B)NSAIDs in urine and plasma samples.
± SD (n = 3)
200 mg L1
% RRd Matrix eﬀect% (n = 6)
50 mg L1 200 mg L1
9.5 97.6 62.4 65.3
10.2 102.2 65.3 70.2
9.8 105.2 38.7 39.0
23.2 93.4 28.3 29.5
9.6 92.7 90.7 95.2
10.2 95.7 98.6 97.4
7.9 102.4 104.3 100.7
16.4 97.4 75.6 77.9
8.7 99.2 62.4 65.3
11.5 86.8 65.3 70.2
9.5 100.7 38.7 39.0
8.9 94.1 28.3 29.5
10.5 102.1 90.7 95.2
9.9 91.5 98.6 97.4
8.9 97.2 104.3 100.7
10.6 102.9 75.6 77.9
ation method based on dispersive liquid–liquid microextraction associated with
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An efﬁcient sample preparation method based on dispersive liquid–liquid microextraction 7sample before (2) and after (1) fortiﬁed with the NSAIDs stan-
dard solution at 200 mg L1, afﬁrming the existence of IBU (A)
and NAP (B). In all real samples analyzed, the presence of
NSAIDs was veriﬁed by both GC–MS analysis and the com-
parison of the obtained mass spectrum Fig. 4-1B and 4-2B)
with the MS database of instrument library Fig. 4-1A and
4-2A. Fig. 4C and D depict the GC–MS chromatograms of
the non-fortiﬁed real plasma and urine sample after the extrac-
tion process, respectively. Fig. 4-1B and 4-2B presents the mass
spectra (SIM mode) of detected NSAIDs in the urine and
plasma samples. As can be observed, the GC–MS resultsFig. 4 MS spectrum in database of instrument library for IBU-TMS
IBU-TMS (1B) and NAP-TMS (2B). The chromatograms B and C in S
real plasma and urine samples after extraction, respectively.
Please cite this article in press as: Ghambarian, M. et al., An eﬃcient sample prepar
back extraction for trace determination of acidic pharmaceuticals. Arabian Journalreafﬁrm the presence of IBU and NAP in the urine and plasma
samples.
4.2. Comparative study
The efﬁciency of the presented method in terms of extraction
time, initial volume of biological ﬂuid samples, LOD, LOQ,
% ER and intra-day precision was compared with the others
reported in the literature and summarized in Table 3. Brieﬂy,
the main advantages of the proposed method are rapidness,
simplicity and requirement to less amount of organic solvent(1A) and NAP-TMS (2A) in comparison with MS spectrum for
cheme 1 and 2 show the GC–MS chromatograms of the non-spiked
ation method based on dispersive liquid–liquid microextraction associated with
of Chemistry (2018), https://doi.org/10.1016/j.arabjc.2018.02.010
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Please cite this article in press as: Ghambarian, M. et al., An eﬃcient sample prepar
back extraction for trace determination of acidic pharmaceuticals. Arabian Journaland real sample for the analysis. Since low consumption of
immiscible organic solvent is applied in the back-extraction
step, this method presented low LODs and LOQs compared
to those of DLLME-SFO method (Ramos and Paya´n, 2009;
Locatelli et al., 2014; Barﬁ et al., 2015; Larsson et al., 2014;
Shukri et al., 2015). Meanwhile, the results obtained indicate
that DLLME in tandem with back-extraction is a promising
joint method for the analysis of NSAIDs at low concentration
levels in biological ﬂuid samples and can be applied for the
analysis of a wide variety of different polar compounds.5. Concluding remarks
Within this study, a simple and efﬁcient method for the extrac-
tion and determination of selected NSAIDs in biological ﬂuid
samples was developed. The method was based on the combi-
nation of DLLME with back-extraction technique in which
two immiscible organic solvents were utilized. We should say
that the back-extraction stage in this work is performed to
address two major issues as following:
1- In fact, we did extract the biological samples using the
DLLME stage alone and what we achieved was the
organic extract phase (2-dedcane and TOPO) full of
unwanted materials which overwhelmed the whole phase
resulting in an enhancement of background signals and
interferences within the matrix.
2- Additionally, the introduction of the above-mentioned
extract phase (2-dedcane and TOPO) to GC and HPLC
could hamper the whole analysis and does severe dam-
ages to the used chromatographic instruments.
In the present method, a further step (back extraction of
targets) is required and therefore the time needed for present
method is higher than other dispersive liquid-liquid microex-
traction methods.
The extraction procedure is relatively simple, efﬁcient,
quick, and low-cost compared to other methods. Other advan-
tages of this joint method include the compatibility with GC
due to using organic acceptor solvent, minimization of the
matrix effect, application of the selective derivatization of
polar puriﬁed compounds by MSTFA prior to GC analysis
and provision of a high clean-up in the analysis of highly com-
plicated biological ﬂuid matrices.
Finally, this simple and robust DLLME-BE method could
be implemented in medical/other laboratories for monitoring
NSAIDs in human ﬂuids.
Appendix A. Supplementary material
Supplementary data associated with this article can be found,
in the online version, at https://doi.org/10.1016/j.arabjc.2018.
02.010.
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